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Abstract
It has been argued that the limited genetic diversity and reduced allelic heterogeneity observed in isolated founder
populations facilitates discovery of loci contributing to both Mendelian and complex disease. A strong founder effect,
severe isolation, and substantial inbreeding have dramatically reduced genetic diversity in natives from the island of Kosrae,
Federated States of Micronesia, who exhibit a high prevalence of obesity and other metabolic disorders. We hypothesized
that genetic drift and possibly natural selection on Kosrae might have increased the frequency of previously rare genetic
variants with relatively large effects, making these alleles readily detectable in genome-wide association analysis. However,
mapping in large, inbred cohorts introduces analytic challenges, as extensive relatedness between subjects violates the
assumptions of independence upon which traditional association test statistics are based. We performed genome-wide
association analysis for 15 quantitative traits in 2,906 members of the Kosrae population, using novel approaches to manage
the extreme relatedness in the sample. As positive controls, we observe association to known loci for plasma cholesterol,
triglycerides, and C-reactive protein and to a compelling candidate loci for thyroid stimulating hormone and fasting plasma
glucose. We show that our study is well powered to detect common alleles explaining $5% phenotypic variance. However,
no such large effects were observed with genome-wide significance, arguing that even in such a severely inbred population,
common alleles typically have modest effects. Finally, we show that a majority of common variants discovered in Caucasians
have indistinguishable effect sizes on Kosrae, despite the major differences in population genetics and environment.
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Introduction
The use of isolated populations has a long history in genetic
mapping, with benefits including founder effects, reduced genetic
diversity, reduced genetic and environmental heterogeneity, and
large, multi-generational pedigrees [1–3]. The resulting reduction
in allelic heterogeneity has contributed to the success of genetic
linkage and positional cloning approaches in isolated populations,
particularly for the identification of Mendelian disease mutations
[1]. While multiple rare mutations may segregate in an outbred
population, founding events and subsequent population bottle-
necks may reduce allelic diversity such that a single mutation
dominates the allelic spectrum in an isolated population. In
addition, previously rare mutant alleles may increase in frequency
through genetic drift or natural selection, thus contributing more
substantially to trait variation than in outbred populations and
increasing the power of genetic mapping studies. Conceivably, the
same properties that make isolated populations valuable for
Mendelian trait genetics may be exploited for genome-wide
association approaches to the study of complex genetic traits [3].
PLoS Genetics | www.plosgenetics.org 1 February 2009 | Volume 5 | Issue 2 | e1000365We have been studying the native population of Kosrae,
Federated States of Micronesia, under the hypothesis that power
to detect mutant alleles might be enhanced by reduced allelic
heterogeneity, and that different genes (and thus biological
insights) might be obtained. Our initial analyses of genotyping
data from 30 Kosraen trios and ,110,000 genome-wide SNPs
showed that Kosraens exhibit strikingly reduced haplotype
diversity and extended LD, likely resulting from a strong founder
effect and repeated population bottlenecks [4–6]. These features
were much more dramatic than in commonly cited ‘‘founder’’
populations such as Finland and Iceland. Our prior analyses,
including resequencing on Kosrae, suggested that fixed marker
sets such as the Affymetrix SNP genotyping products would
provide better coverage for common variants in Kosraens than in
any HapMap population [4].
We also previously observed that native Kosraens exhibit
elevated rates of obesity and diabetes, as seen in other indigenous
populations [7–10]. It is likely that many common mechanisms
underlie the rising prevalence of obesity and metabolic disease in
both Caucasian and native populations. However, given the
reduced genetic diversity of isolated populations, the high
prevalence of metabolic disease raises the possibilities that
population-specific disease loci and fewer disease loci of relatively
larger effect segregate in Kosraens.
The genetic architecture of isolated populations introduces
analytic challenges which confound traditional association tests
[11]. Inbreeding and the historical lack of random mating in a
small population violate assumptions such as Hardy-Weinberg
equilibrium which underlie many association test statistics.
Members of isolated populations descend from a small number
of founders, thus are related, typically in large families. In addition
to ‘‘known’’ relationships, cryptic relatedness further confounds
the test statistic, as more distant relationships may be unreported
or incorrectly specified during patient interview.
We ascertained over 3,100 Kosraen adults in three screens
spanning a decade and performed genome-wide association
studies for 15 quantitative traits in this cohort. To do so, we
developed analytic strategies to address the complexities of
studying a population in which the majority of subjects are
related. Our work includes: extensive validation of the extended
Kosrae pedigree; identifying an analytic approach to maximize
power; calibrating the association score to correct for relatedness
in the cohort; and application of this method to the analysis of 15
quantitative traits. Results from the genome-wide association
analyses validate our approach by detecting previously known loci
for LDL-C, HDL-C, triglycerides and C-reactive protein.
Additionally, our data suggest novel loci contributing to
phenotypic variation in thyroid stimulating hormone (TSH) and
fasting plasma glucose (FPG). While empirical power calculations
suggest our study is well-powered to detect common variants of
relatively large effect ($5% variance explained) with genome-wide
significance, no such effects were observed in our data with
convincing statistical support.
Results
Sample Ascertainment
We performed a population-based screen of native Kosraens
over three separate visits to the island (Table 1). The 1994 cohort
was described previously [7,12]. Self-reported family relationships
were recorded for use in constructing pedigrees and blood was
collected for DNA extraction and genotyping. A rich phenotypic
dataset was collected for a majority of the adult population of the
island, including measurements of height, weight, body mass index
(BMI), waist circumference, plasma leptin, percent body fat,
fasting plasma glucose, blood pressure, plasma lipids (ApoA1,
HDL-C, ApoB, LDL-C, total cholesterol, triglycerides), thyroid
stimulating hormone (TSH), and plasma C-reactive protein
(CRP). Phenotypic data were carefully reviewed for errors in data
entry, unit conversion and spurious measurements, and to verify
that measurements of related traits are correlated (e.g.,r
2.0.7
between BMI and waist circumference). Any values that could not
be reconciled were excluded from the analysis. Heritability
estimates for each trait are typically within published ranges;
mean values, distribution, number of phenotyped individuals, and
heritability estimates for each trait can be found in Dataset S1.
Genotyping
A total of 2,906 individuals were successfully genotyped using
the Affymetrix 500 k mapping assay (minimum per-chip call rate
95%) (Table S1). SNPs were excluded from the analysis for the
following reasons: mapping to multiple genomic locations
(n=3,462); missing .5% data (n=43,849); or more than 10
Mendelian errors observed (n=5,887) (Figure S1). Hardy-Wein-
berg equilibrium was not used as a quality filter, as it is difficult to
assess in our highly related cohort using standard formulae. For
the purposes of SNP quality control, allele frequencies were
estimated assuming all 2,906 genotyped individuals are unrelated.
After excluding monomorphic SNPs (n=30,581), 408,775 SNPs
passed technical quality filters, including 78,862 SNPs of very low
frequency in Kosraens (0,MAF,0.01).
We next used data from 2,906 individuals genotyped for
400,301 polymorphic, autosomal SNPs to validate the Kosrae
pedigree.
Refining the Kosrae Pedigree with Genome-Wide Genetic
Data
Genetic accuracy of the Kosrae pedigree was assessed using
pairwise identity-by-descent (IBD) estimates generated in PLINK
[13]. For three types of known relationships (parent-child, full
sibling, and half-sibling), pairs of genotyped individuals were
evaluated to determine whether estimates of the proportion IBD
Author Summary
Isolated populations have contributed to the discovery of
loci with simple Mendelian segregation and large effects on
disease risk or trait variation. We hypothesized that the use
of isolated populations might also facilitate the discovery of
common alleles contributing to complex traits with
relatively larger effects. However, the use of association
analyses to map common loci influencing trait variation in
large, inbred cohorts introduces analytic challenges, as
extensive relatedness between subjects violates the as-
sumptions of independence upon which traditional associ-
ation test statistics are based. We developed an analytic
strategy to perform genome-wide association studies in an
inbred family containing over 2,800 individuals from the
island of Kosrae, Federated States of Micronesia. No alleles
with large effect were observed with strong statistical
support in any of the 15 traits examined, suggesting that
the contribution of individual common variants to complex
trait variation in Kosraens is typically not much greater than
that observed in other populations. We show that the
effects of many loci previously identified in Caucasian
populations are indistinguishable in Caucasians and Kos-
raens, despite very different population genetics and
environmental influences.
GWAS on the Island of Kosrae
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reported by the patients and their families. The pedigree was
corrected to reflect the true genetic relationship between pairs of
individuals whose IBD estimates were inconsistent with self-
reported relationships (Table 2). For example, 2,553 parent-child
pairs reported by study participants were validated by genetic
data, while 141 parent-child pairs were identified using IBD
estimates where the relationship was previously unknown, was
misreported, or not reported by study participants. In some cases,
individuals were added to the pedigree as ‘‘placeholders.’’ For
example, if genetic data indicated that one individual of a reported
sibship was actually a maternal half-sibling, an ungenotyped
‘‘placeholder’’ was added to the pedigree as the father of the
newly-discovered half-sib. Discrepancies between the genealogical
and genetic pedigrees on Kosrae are not unexpected given the
inherent inaccuracies of self-reported relationships, and are also
consistent with known adoption practices on the island.
Changes to the pedigree were made based on data from a
related pair in which both individuals were genotyped. However,
successive iterations of pedigree validation and correction for fully
genotyped, first-degree relatives produced a ‘‘ripple effect,’’ also
improving the accuracy of relationships involving individuals not
genotyped with the 500 k assay (Table 2), and second-degree and
other higher-order relationships across the extended pedigree.
After extensive comparisons with genetic data, the extended
Kosrae pedigree spans eight generations and includes over 4,300
individuals (living or deceased), averaging four individuals per
sibship (range 1–12). Nearly all (n=2,900) of the subjects
successfully genotyped with the Affymetrix 500 k assay can be
joined in a single extended pedigree, with an additional six
individuals forming three independent nuclear families. We count
58 consanguineous offspring as well as numerous marriage loops.
Nearly 30% of all genotyped individuals have two genotyped
parents. Fifty-six individuals appear distantly related or unrelated
to any other study participants.
Development of a Strategy for Association Analyses
Our goal was to develop an analytic framework that
accommodates the complex familial relationships in the Kosraen
cohort while maximizing power to detect association. We were
unable to identify or develop software capable of simultaneously
computing over a complex pedigree of 2,900 individuals and
.330,000 SNPs. Thus, our strategy became to break the pedigree
into smaller units; a similar approach was recently taken by
Przeworski and colleagues in their study of recombination in the
Hutterites [14]. Below we also describe the data simulation
framework used to perform controlled comparisons between
analytic approaches, leading to the selection of an association
test. We use empirical power calculations to determine an effective
sample size for our highly related cohort and estimate the power of
our study across a range of effect sizes. We applied our method for
association analyses in a related cohort to the study of 15
quantitative traits in native Kosraens.
Table 1. Study participants successfully genotyped for the Affymetrix 500 k assay.
N total N unique % Male/Female Mean age Median age Age Range
1994 1,935 903 49.6%/50.4% 43 39 20–86
2001 1,968 889 40.8%/59.2% 28 24 16–80
2003 84 33 51.5%/48.5% 24 22 16–53
Multiple exams - 1,081 35.3%/64.7% 47 46 17–89
Total 3,987 2,906 41.6%/58.4% 40 38 16–89
Screenings took place in 1994, 2001, and 2003. For each screen, the total and unique number of individuals examined is shown, as some participants were examined in
multiple screens. For subjects examined more than once, age (years) is reported from the most recent exam.
doi:10.1371/journal.pgen.1000365.t001
Table 2. Evaluation and refinement of the extended Kosrae pedigree using identity-by-descent estimates.
Relationship type Confirmed Conflicting Newly discovered
Two individuals genotyped Parent-Child 2,553 2 141
Full sibling 4,147 72 110
Half sibling 351 72 271
One individual genotyped Parent-Child 3,266 229 109
Full sibling 2,384 126 33
Half sibling 162 28 104
No individuals genotyped Parent-Child 1,415 43 28
Full sibling 941 34 21
Half sibling 51 0 18
For each type of relationship, the number of related pairs is shown where the reported relationship and identity-by-descent estimates from genetic data were in
agreement (‘‘Confirmed’’), conflicting, or added based on genetic data (‘‘Newly discovered’’). Estimates for genome-wide IBD sharing and sharing 0, 1, or 2 copies IBD
were used to distinguish between the three relationship types. Individuals were added to the pedigree as necessary to represent genetic relationships, such as the
addition of a ‘‘placeholder’’ father to reflect a newly-discovered maternal half-sib relationship. Corrections to the pedigree were made based on data from related pairs
with two genotyped individuals, but impacted relationships throughout the extended pedigree.
doi:10.1371/journal.pgen.1000365.t002
GWAS on the Island of Kosrae
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We broke the extended pedigree to create smaller units that
could be feasibly analyzed by existing software packages for large
numbers of markers, while maximizing the number of genotyped
individuals included in the analysis (as an initial, rough proxy for
power) and maintaining some degree of information about
relatedness between study participants. Alternative methods for
breaking the pedigree were systematically explored, as described in
the Materials and Methods.
We selected sibships-without-parents as the unit of analysis
(Figure 1A). The 2,848 non-consanguineous genotyped Kosraens
were grouped into 586 sibships consisting of two or more
individuals who share a mother and father (Figure 1B). Any
genotyped parents are considered only in the context of the
parents’ sibship. Of the individuals not included in a sibship of size
$2 (n=612), a subset was identified in which any two members of
the subset were related to the degree of first cousins or less, as
determined by genome-wide IBD sharing. In the context of
association analyses, this subset of individuals can be considered as
sibships of size one, where relatedness between family groups is no
more than first cousins.
The actual number of individuals included in the association
analysis varies with the availability of phenotypic data, as
individuals lacking phenotype data were omitted from the analysis
of each trait. The extended Kosrae pedigree was thus broken into
sibships for analysis of each of 15 quantitative traits. For example,
in LDL-C, 560 sibships size $2 and 240 sibships of size 1
(n=2,366 individuals total) were analyzed for association. For
BMI, the analysis was limited to individuals who had reached full
adult height (females age $22 and males age $24) [15], and
comprised 2,073 individuals in 467 sibships of size $2 and 202
sibships of size 1.
Since the Kosrae cohort spans multiple generations, members of
one sibship are frequently parents or cousins of other sibships.
Because traditional association tests assume independence between
family groups, we anticipated that relatedness between sibships
would inflate the association test statistic [16,17].
Selection of an Association Test: Within and between
Families
We used simulation to evaluate association tests and the
distribution of association statistics, with the goal of selecting an
association test that maximized power for our chosen family
configuration of sibships-without-parents. We compared two
different approaches for association analyses of quantitative traits:
a within-family test vs. a combined within- and between-family
test. We selected the FBAT software to represent within-family test
statistics, with the expectation that it would be robust to
population stratification and relatedness between families [18].
The QFAM module in PLINK includes options for within-only
(PLINK/QFAM-Within) as well as within- and between-family
tests (PLINK/QFAM-Total) [13]. Both options of PLINK/
QFAM use permutation testing to derive empirical p-values;
however, we expected the between-family test to exhibit score
inflation due to known relatedness between sibships.
We used a modified simulation framework to evaluate and
compare performance of the association approaches. An effect of
known size was spiked into a Kosraen phenotype (BMI) and
analyzed using observed Kosraen genotypes and family structure.
We chose to modify an observed phenotype instead of simulating
genotypes in order to preserve the complex familial correlations
between genotype and phenotype on Kosrae. We selected BMI as a
representative quantitative phenotype for its moderate heritability
(h
2=0.47 on Kosrae) and near-complete phenotyping inour cohort.
Genotype data for 1,000 SNPs were randomly drawn from the
larger dataset. After omitting rare SNPs (MAF,0.01), 770 SNPs
remained. For each simulation, we modified the BMI phenotype to
contain an association toa singleSNP contributinganadditional1%
to the total phenotypic variance. While this constitutes a fairly
substantial single locus effect, it constitutes a small influence on the
trait as a whole that does not distort the overall heritability and
genome-wide relationships between genotype and phenotype. A
total of 770 modified phenotypes were generated, each containing
an artificial association to a different SNP inaddition to the heritable
and othervariation inthe observed BMI phenotype. Acrossdatasets,
the randomly-selected SNP associated with the spiked-in effect
spanned a range of allele frequencies greater than 0.01.
Each dataset was analyzed in parallel using FBAT for a within-
family association test, or using PLINK/QFAM for within-only or
combined within- and between-family tests. The performance of
each method was evaluated by tallying across datasets the rank of
the spiked SNP within its respective dataset. The method that
consistently assigned a higher rank to the spiked SNP was
identified as the more powerful approach for association analyses.
While genomic control is used in the actual association tests to
control the false positive rate, we note that rank order is not
changed by genomic control, and thus we did not employ it at this
stage of evaluating methods.
Figure 1. Breaking the extended Kosrae pedigree. A) The
extended Kosrae pedigree is broken into sibships without parents.
Parent-child or cousin relationships may exist between different
sibships. Tests of association are performed within sibships (gray
arrows) and between sibships (black arrows). Individuals without
siblings (sibships of size 1) are filtered based on genome-wide IBD
sharing to produce a maximal set of individuals with pairwise
relationships equivalent to first cousins or less. Panel B shows the
number of sibships of each size for n=2,848 Kosraen individuals
genotyped with the Affymetrix 500 k assay.
doi:10.1371/journal.pgen.1000365.g001
GWAS on the Island of Kosrae
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between-family association test confirmed that greatest power, as
measured by the rank order of the true effects, was obtained
through the use of a combined within- and between-family
association test (Figure 2). Within-family tests implemented in
FBAT and PLINK/QFAM-Within identified the spiked SNP as
the best result in 36% and 43% of all spiked datasets, respectively.
A combined within- and between-family test as implemented in
PLINK/QFAM-Total increased identification of the spike as the
best-associated SNP to 68%. PLINK/QFAM-Total also ranked a
greater proportion of spiked SNPs in the top 5 results than FBAT
(78% PLINK/QFAM-Total vs. 65% FBAT), indicating that the
between-family test adds substantial power to the study. In a full
genome scan of ,340,000 markers, these rank thresholds
approximately correspond to the top 440 or 2,200 results,
respectively, for a true effect explaining 1% of the variance.
We then examined p-value distributions for the PLINK/
QFAM-Within and PLINK/QFAM-Total tests (data not shown).
As expected, p-values for the within-family test follow the null
distribution while the combined within- and between-family
(QFAM-Total) test exhibited a systematic deviation from the null.
Such inflation of the nominal association score is typical for
genotyping artifacts as well as excess known or cryptic relatedness
in a between-family test of association, and was anticipated from
the known relatedness between sibships. We determined that the
major source of score inflation in the combined within- and
between-family association test (QFAM-Total) was relatedness in
the cohort (Dataset S1, Figure S2). Conceptually, including closely
related family units resembles population stratification, as the allele
frequencies (from IBD) and phenotypes (from heritability and
shared environment) are correlated in family members. In all
subsequent analyses, we applied genomic control to adjust the
association scores for excess relatedness [19].
After calibrating the distribution of test statistics to the null, we
again evaluated the within-only vs. within- and between-family
association tests using p-values to compare performance and to
assess study power. Because the ability to estimate power
accurately is poor when power is very low, we sought to improve
power to discriminate between performances of the two tests by
examining the spiked dataset containing an effect explaining 2%
phenotypic variance. Using p-values as the measure of signifi-
cance, we confirmed that the combined within- and between-
family association test implemented in PLINK/QFAM-Total has
24.4% power compared to the within-family only test at 15.3%
power to achieve an arbitrary threshold of p,10
26 (Figure 3).
Based on these preliminary analyses, we selected an analytic
strategy as follows. The extended Kosrae pedigree is broken into
smaller family units, namely sibships without parents. The
remaining individuals are filtered on identity-by-descent estimates
to produce a set of individuals related no more closely than first
cousins, i.e. sibships of size one. The complete set of all sibships is
filtered for each trait to include only individuals who are both
successfully genotyped and phenotyped. Sibships are analyzed
using a combined within- and between-family association test as
implemented in PLINK/QFAM-Total, including permutation
testing to correct for within-family correlation between genotype
and phenotype. Finally, we compensate for relatedness between
family units and any residual stratification by applying genomic
control.
Empirical Power Calculations
We used the simulation data above to estimate the effective
sample size for the BMI phenotype by direct observation for small
effects (Figure 4A) and by extrapolation for larger effects
(Figure 4B). Power from the 2,073 individuals analyzed in
Kosraen sibships for BMI is comparable to that obtained from a
study of 840 unrelated individuals. The more than two-fold size
reduction from the actual cohort composed of sibships to an
effective number of unrelated individuals highlights the excess of
relatedness among our study participants.
Figure 2. Inclusion of a between-family test of association increases study power using rank as a metric. A known effect comprising 1%
of phenotypic variance explained was ‘‘spiked’’ into a dataset of 770 randomly selected SNPs with MAF$0.01. Study power was evaluated for within-
only (FBAT and PLINK/QFAM-Within) and within- and between-family (PLINK/QFAM-Total) tests of association. Across the 770 spiked datasets
generated, study power is measured as the fraction of datasets in which the ‘‘spiked’’ SNP exceeds a particular rank. Ranking first out of 770 SNPs in
each dataset approximates a rank of #440 in the context of a full genome-wide scan of ,340,000 markers.
doi:10.1371/journal.pgen.1000365.g002
GWAS on the Island of Kosrae
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Genetic Power Calculator [20] to estimate study power for effects
explaining larger proportions of phenotypic variance, as our
hypothesis was that such effects might exist on Kosrae (Figure 4B).
Our study has ,87% power to detect effects explaining 5%
phenotypic variance at a genome-wide significant threshold of
p,5610
28, and .95% power to detect such effects at p,10
26.
We concluded that our genome-wide association strategy for
quantitative traits on Kosrae is well-powered to identify loci with
relatively strong genetic effects, should they exist and are tagged by
SNPs on the genotyping array.
Results from the Genome-Wide Association Analyses of
15 Quantitative Traits
We applied our strategy for association analyses to the
examination of 15 quantitative traits, using measurements from
clinical screenings in 1994, 2001 and 2003. As anticipated from
the known relatedness between sibships, scores were inflated
compared to the null distribution. Score inflation ranged from
l=1.10 for fasting plasma glucose to l=2.05 for HDL-C (Figure
S3). Score inflation was correlated strongly with trait heritability
(r
2=0.42). For reference, Table 3 provides a list of SNPs with
p#10
25 for each trait, including genome-wide significant
association (p#5610
28) between SNPs on chromosome 11 and
triglycerides. Quantile-quantile (QQ) plots and the respective
genomic control correction factors (l) for select traits are shown in
Figure 5; plots for all 15 quantitative traits are presented in Figure
S3. The results from our genome wide scans indicate an excess of
association signal over that expected by chance for LDL-C,
triglycerides and thyroid stimulating hormone.
We observed strong association between SNPs in previously
established loci and HDL-C, LDL-C, triglyceride levels, TSH and
CRP, supporting the validity of our analytic approach. For HDL-
C, we observe association with rs4783962 and rs1800775 near
CETP (p=1.68610
24 and 1.71610
24, respectively), with the
same allele and direction of effect as reported in Caucasian
populations [21,22]. The best-associated SNP for LDL-C is
rs4420638 in the APOE/C1/C4/C2 gene cluster on chromosome
19 (p=1.89610
27), a known locus influencing plasma levels of
LDL-C and total cholesterol [23]. We also observed association
between LDL-C levels and multiple SNPs in and around the gene
encoding HMG-CoA reductase (HMGCR), the target for choles-
terol-lowering statin drugs [24,25]. Studies in Caucasian cohorts
recently established this locus as a true association, with genome-
wide significant p-values ,1610
220 [21]. For TSH, three SNPs
(rs4704397, rs6885099, and rs2046045) previously identified in
Caucasian cohorts are also associated in Kosraens, with p-values
ranging from 3610
24 to 1.8610
24 [26]. For CRP, SNPs at the
CRP and HNF1A gene loci show association and the same
direction of effect on Kosrae (p=2.0610
25 and 3610
24,
respectively) as previously observed in a Caucasian cohort, in
which the associated SNPs were either directly genotyped or are in
perfect correlation (r
2=1 in both HapMap CEU and ASN) [27].
The strongest association for CRP on Kosrae is with rs4420638
near the APOE gene (p=1.6610
26; Table 3), another previously
known locus [27,28]. This SNP is less well-correlated with the
most highly-associated SNP reported in the literature (rs2075650;
r
2=0.37 and 0.49 in HapMap CEU and ASN, respectively) [27].
Seven SNPs near APOC3/A5 have genome-wide significant
association (p,5610
28) with triglyceride levels (p=1.2610
29 to
8.6610
29), including specific variants not previously implicated in
Caucasian cohorts. In Kosrae, the best-associated SNP for
triglyceride levels (rs7396835, p=1.2610
29)i s,23 kb down-
stream of the variant recognized in Caucasians (rs2266788).
Correlation between these two SNPs has not been evaluated in
Kosraens, since rs2266788 is neither directly genotyped nor well-
covered by other SNPs in our 500 k dataset. However, rs2266788
is uncorrelated in HapMap Asian or Caucasian samples (r
2#0.32
and r
2#0.14, respectively) with any of the seven SNPs associated
with triglycerides in Kosraens. As the causal variant for this locus
has not been identified, it remains to be determined whether these
Figure 3. Inclusion of a between-family test of association increases study power using p-value as a metric. A known effect comprising
2% of phenotypic variance explained was ‘‘spiked’’ into a dataset of 770 randomly selected SNPs with MAF$0.01. Study power was evaluated for
within-only (PLINK/QFAM-Within) and within- and between-family (PLINK/QFAM-Total) tests of association. After calibrating the score distribution to
the null using genomic control, study power is measured as the fraction of datasets in which the ‘‘spiked’’ SNP exceeds a particular p-value threshold.
doi:10.1371/journal.pgen.1000365.g003
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whether independent causal variants segregate in these two ethnic
groups. Besides SNPs near APOC3/A5 and triglycerides, no other
loci across all 15 traits achieved genome-wide significance
(Table 3).
The most compelling evidence for a novel finding is observed in
the association results for thyroid stimulating hormone (TSH).
Among the top 20 results for TSH, 10 SNPs (p=9.9610
27 to
4.8610
26) map to chromosome 9 at 97.6–97.8 Mb, a region
encompassing the gene thyroid transcription factor 2 (TTF-2)
Figure 4. Study power over varying effect sizes. A known effect explaining 0.5%, 1% or 2% of phenotypic variance was ‘‘spiked’’ into a dataset
of 770 randomly selected SNPs with MAF$0.01. Study power was evaluated using a combined score from within- and between-family tests of
association (QFAM-Total) with genomic control. A) Of 770 spiked datasets generated, power is measured as fraction of datasets in which the ‘‘spiked’’
SNP exceeds a particular p-value threshold. These data were used to estimate an effective sample size for Kosrae, from which power estimates for
effects explaining up to 8% of phenotypic variance were generated (panel B).
doi:10.1371/journal.pgen.1000365.g004
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25 for 15 quantitative traits.
Rank Chr Position (Mb) SNP A1 A2 MAF P-value b Var expl Nearest Gene(s)
BMI
1 10 1.7 rs6560749 T G 0.14 2.0E-06 20.32 2.4% adarb2
Height
1 7 41.3 rs10486715 A G 0.07 3.1E-06 20.44 2.6%
2 7 41.3 rs17718077 C G 0.07 3.1E-06 20.44 2.5%
Waist Circumference
1 3 160.7 rs2222328 C T 0.32 8.4E-07 20.22 2.1% schip1
2 9 22.7 rs613391 G C 0.49 5.3E-06 0.20 1.9%
3 9 22.6 rs527485 A G 0.50 6.7E-06 0.19 1.8%
4 9 22.7 rs976731 T A 0.47 7.3E-06 0.19 1.9%
5 9 22.7 rs976730 A T 0.47 8.4E-06 0.19 1.8%
Weight
1 9 24.1 rs2225614 C A 0.50 2.8E-06 20.21 2.3%
2 2 144.3 rs10928195 C G 0.08 4.1E-06 20.36 1.9% arhgap15
3 7 137.6 rs1874326 G A 0.47 9.0E-06 0.22 2.3% trim24
Leptin
1 3 31.5 rs882648 A G 0.36 1.2E-05 20.14 0.9% ensg00000181233
% body fat
1 20 44.9 rs6066084 A G 0.06 1.5E-06 0.85 8.7%
2 20 44.9 rs6018089 C T 0.06 1.6E-06 0.86 9.1%
3 20 44.9 rs6066085 C T 0.07 2.1E-06 0.85 8.9%
4 10 1.7 rs6560749 T G 0.14 7.5E-06 20.34 2.7% adarb2
5 8 3.8 rs2554622 C A 0.42 9.7E-06 0.23 2.5%
HDL-C
1 5 180.2 rs655601 A C 0.47 5.3E-06 0.23 2.6% mgat1
2 6 22.9 rs10498712 G A 0.25 8.7E-06 0.23 2.1%
LDL-C
1 19 50.1 rs4420638 G A 0.21 1.9E-07 0.31 3.1% tomm40,apoc2,apoe,apoc4,apoc1
2 19 50.4 rs2159324 T C 0.44 3.7E-07 20.21 2.2% mgc2650,bloc1s3,xtp7
3 5 74.7 rs3846663 T C 0.39 1.3E-06 0.21 2.1% col4a3bp,hmgcr
Total Cholesterol
1 19 50.1 rs4420638 G A 0.21 3.4E-07 0.28 2.5% tomm40,apoc2,apoe,apoc4,apoc1
2 10 15.5 rs7917302 C G 0.03 1.9E-06 20.39 0.9%
3 19 50.4 rs2159324 T C 0.44 2.3E-06 20.19 1.8% mgc2650,bloc1s3,xtp7
4 5 74.7 rs3846663 T C 0.39 5.5E-06 0.19 1.7% col4a3bp,hmgcr
5 10 15.8 rs7895372 G C 0.04 6.0E-06 20.35 1.0% itga8
6 7 8.8 rs17157663 A G 0.32 8.8E-06 20.18 1.5%
7 7 8.8 rs16874905 T C 0.32 9.9E-06 20.18 1.5%
Triglycerides
1 11 116.2 rs7396835 T C 0.32 1.2E-09 0.23 2.3%
2 11 116.2 rs7396851 T C 0.32 1.2E-09 0.23 2.3%
3 11 116.2 rs2727789 G T 0.34 2.1E-09 0.22 2.2%
4 11 116.2 rs2071521 G A 0.34 2.2E-09 0.21 2.0%
5 11 116.2 rs2849176 T C 0.34 2.9E-09 0.22 2.1%
6 11 116.2 rs2071523 C T 0.34 3.9E-09 0.21 2.1%
7 11 116.2 rs6589567 C A 0.37 8.6E-09 20.21 2.2% mgc13125,ensg00000110244,apoc3,apoa5,znf259
8 19 49.6 rs2722750 C G 0.39 3.8E-06 0.16 1.3% znf228,znf285
9 19 40.3 rs12978414 G C 0.14 4.0E-06 0.28 1.9% ensg00000179066,fxyd5,ensg00000126258,lgi4,fxyd3,fxyd7
10 19 50.1 rs4420638 G A 0.21 5.0E-06 0.22 1.6% tomm40,apoc2,apoe,apoc4,apoc1
11 4 80.9 rs10518224 A G 0.23 6.7E-06 0.19 1.3%
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Systolic BP
1 10 18.8 rs7069923 C T 0.49 1.1E-06 0.19 1.8% cacnb2
2 7 156.6 rs2527866 C A 0.23 2.9E-06 20.27 2.5% ube3c
3 10 18.8 rs4237348 T C 0.50 3.1E-06 0.18 1.5% cacnb2
4 10 18.8 rs4628581 A C 0.49 3.7E-06 0.18 1.5% cacnb2
5 7 156.6 rs2527865 T C 0.23 3.8E-06 20.27 2.5% ube3c
Diastolic BP
1 5 171.0 rs254893 A G 0.06 5.5E-06 20.58 4.1%
2 10 17.0 rs10508517 A G 0.43 6.1E-06 20.18 1.5% cubn
Fasting plasma glucose
1 10 50.2 rs10745259 T C 0.29 1.9E-05 0.19 1.5% c10orf71
Thyroid Stimulating Hormone
1 9 97.8 rs755109 C T 0.23 9.9E-07 20.31 3.3% hemgn,c9orf156
2 7 3.7 rs6462411 C T 0.20 1.3E-06 20.36 4.2% sdk1
3 9 97.7 rs10983893 C T 0.15 1.6E-06 20.31 2.4%
4 12 2.8 rs10848704 C T 0.35 1.7E-06 20.29 3.7% ensg00000118975,fkbp4
5 9 97.7 rs4743136 G C 0.25 1.7E-06 20.29 3.0%
6 7 3.7 rs10241703 T C 0.20 2.1E-06 20.34 3.7% sdk1
7 7 3.7 rs6958535 C T 0.20 2.6E-06 20.34 3.7% sdk1
8 9 97.6 rs925488 G A 0.19 2.6E-06 20.29 2.7%
9 9 97.7 rs10983932 T A 0.15 2.6E-06 20.31 2.4%
10 7 3.7 rs6959674 C T 0.20 3.2E-06 20.33 3.6% sdk1
11 7 3.7 rs11514766 T C 0.20 3.4E-06 20.34 3.7% sdk1
12 7 3.7 rs7804166 C T 0.20 3.4E-06 20.34 3.7% sdk1
13 9 97.6 rs1877431 A G 0.19 3.5E-06 20.29 2.7%
14 9 97.6 rs1588635 A C 0.19 3.9E-06 20.29 2.6%
15 9 97.8 rs10984516 T C 0.13 4.0E-06 20.33 2.4% hemgn,anp32b
16 7 3.7 rs1962785 C G 0.20 4.2E-06 20.34 3.6% sdk1
17 9 97.6 rs2805809 A G 0.18 4.3E-06 20.28 2.3%
18 7 3.6 rs12531984 G A 0.20 4.5E-06 20.34 3.7% sdk1
19 7 3.7 rs10243770 C T 0.18 4.7E-06 20.37 4.0% sdk1
20 9 97.7 rs10119795 C T 0.27 4.9E-06 20.27 2.8% c9orf156
21 7 3.6 rs12539695 G C 0.19 5.6E-06 20.34 3.6% sdk1
22 9 97.4 rs2805810 T C 0.16 5.7E-06 20.28 2.2% tmod1
23 7 3.7 rs6956479 G C 0.20 6.0E-06 20.34 3.7% sdk1
24 9 97.6 rs2668804 A C 0.18 6.1E-06 20.28 2.3%
25 9 97.7 rs7036589 A T 0.14 7.2E-06 20.30 2.2% c9orf156
26 6 98.8 rs6909430 G A 0.08 8.1E-06 20.49 3.8%
27 9 97.6 rs2808693 G A 0.18 9.6E-06 20.28 2.3% ensg00000188515
28 7 3.7 rs10245389 C T 0.20 9.9E-06 20.34 3.7% sdk1
C-reactive protein
1 19 50.1 rs4420638 G A 0.21 1.6E-06 20.28 2.6% tomm40, apoc2, apoe, apoc4, apoc1
2 12 112.4 rs11066587 G C 0.16 4.5E-06 0.26 1.8%
3 12 119.7 rs1039302 T C 0.36 5.2E-06 0.21 2.0% sppl3
4 2 24.2 rs7561273 A G 0.32 6.1E-06 20.22 2.1% ensg00000173957, ubxd4, fkbp1b, flj21945
5 12 119.7 rs10437838 T A 0.35 6.2E-06 0.21 2.0% sppl3
6 12 112.4 rs11066595 G C 0.16 6.8E-06 0.26 1.8%
7 2 24.0 rs17711796 C T 0.35 7.3E-06 20.22 2.2% ensg00000163019
8 12 119.7 rs10431387 G A 0.36 8.0E-06 0.21 2.0% sppl3
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in conjunction with thyroid agenesis and congenital hypothyroid-
ism in humans [29–31]. The two best-associated SNPs for TSH,
rs755109 and rs10983893, are located ,19 kb upstream and
,77 kb downstream of the TTF-2 coding region, respectively.
Analyses conditioning on the best-associated SNP, rs755109,
suggest that a single association signal underlies association
between SNPs in this region and plasma levels of TSH in
Kosraens (data not shown).
In another example of association observed near a strong
biological candidate, rs10998046 on chromosome 10 near
MAWBP (MIM 612189) is modestly associated with fasting plasma
glucose in Kosraens (p=1.12610
24). Upregulated expression of
this gene has been reported in rat models of insulin resistance [32].
Meta-analysis of these data with publicly available results from the
Diabetes Genetics Initiative [33] produces a combined p-value of
2.10610
26, with 7 other neighboring SNPs producing combined
p-values of 2.53610
26 to 5.73610
26. While extended linkage
disequilibrium limits our ability to identify the causal variant in
Kosraens or to exclude association to other genes in the associated
region, these loci represent promising results for follow-up in other
cohorts.
Evidence for Many Variants of Small Effect Segregating
on Kosrae
Our study was motivated by the hypothesis that the reduction in
allelic heterogeneity resulting from the founder effect on Kosrae,
combined with drift and natural selection, might produce common
variants with relatively large effects segregating through the
population. Empirical power calculations demonstrated that
effects $5% should be readily detected (95% power) at p#10
26.
Given these power calculations, and the evidence for a series of
known associated loci as described above, the consistent lack of
strong association across the majority of traits argues strongly that
common variants of large effect are unusual on Kosrae (Table 3),
as they are in the larger populations studied to date in GWAS.
The best observed p-value for each trait at a novel locus ranged
from 1.9610
25 for fasting plasma glucose (rs10745259) to
8.4610
27 for waist circumference (rs2222328). Only two of fifteen
traits, TSH and waist circumference, have strong, novel
associations with p#10
26. No novel associations were detected
in any trait with p,8610
27. Interestingly, these data indicate that
on Kosrae, common variants in LD with SNPs on the genotyping
array are of small effect in this founder population, similar to the
genetic architecture observed in Caucasian populations.
If the effect sizes for common variants are similar in Kosraens
and Europeans, then the lack of strong associations is unsurprising
given the modest size of our cohort. We observe modest evidence
for SNPs near multiple other loci which have been convincingly
replicated in other cohorts [21,22,27,33,34], including HDL-C
and LPL (p=0.025, rs17411024) or LIPC (p=4.5610
23,
rs11071386); triglycerides and GCKR (p=0.015, rs780094), and
LDL-C and APOB (1.6610
23, rs7575840). These and other
common variants of small effect identified in Caucasian popula-
tions may also influence trait variation on Kosrae, despite lack of
genome-wide statistical significance for association.
Comparison of Effects and Allele Frequencies in
Caucasians and Kosraens for Known Associated Loci
We examined data for previously associated SNPs not under the
null hypothesis of no effect on trait value, but rather under the
alternative hypothesis that the effect seen in Europeans was also
observed on Kosrae. We compared the effect sizes (b-coefficients)
and allele frequencies for known loci in Caucasians to those
observed in our study. Specifically, we identified 45 established
associations for BMI, height, lipids, fasting plasma glucose, TSH
and CRP (Table 4) where the best-associated SNP in the literature
was directly genotyped in Kosraens or had a strong proxy
(r
2$0.95) in HapMap Caucasians and Asians [18–22,34–36]. A
test of heterogeneity for the magnitude and direction of b-
coefficients was performed for 39 SNPs with MAF$0.05. Six
SNPs were omitted from the comparison of effect sizes, as there is
little power to estimate the individual effects for SNPs observed at
very low frequencies.
Of the 39 SNPs examined for effect sizes on Kosrae, only 6 loci
had significantly different (p#0.01) effects in Caucasians and
Kosraens (p=5.5610
242 to 6.8610
24), of which 4 SNPs were
associated with height in Caucasians. Over 70% of the loci
evaluated (n=28) had effects which were of indistinguishable
magnitude and direction (p$0.1) in the two populations.
We next considered whether differences in allele frequency
could underlie the lack of association in Kosraens to loci with
strong support in European studies. Of 45 established associations
(Table 4), allele frequencies were compared for 36 SNPs directly
typed on the Affymetrix array. For each risk allele, we identified
SNPs on the Affymetrix array with frequencies in HapMap CEU
within 2% of the risk allele frequency in HapMap CEU. For that
set of SNPs, we generated a distribution of allele frequency
differences between HapMap CEU and Kosrae. To determine
whether a risk allele has an unusual difference in frequency
between Kosraen and HapMap CEU, we examined the difference
in frequency for the risk allele in the context of the complete
distribution of allele frequencies. Over 85% of the SNPs evaluated
(n=32) have statistically indistinguishable frequencies in Kosraens
and Europeans (empirical p$0.1) while none of the loci examined
had significantly different (empirical p#0.01) frequencies in the
two populations.
Rank Chr Position (Mb) SNP A1 A2 MAF P-value b Var expl Nearest Gene(s)
9 12 119.7 rs6489780 G C 0.35 8.4E-06 0.20 1.8% sppl3
10 12 119.7 rs10849788 A G 0.36 9.0E-06 0.20 1.8% sppl3
11 2 23.9 rs2081302 A C 0.34 9.2E-06 20.22 2.2% ensg00000119778, ensg00000119771
12 12 119.8 rs3809314 A G 0.36 9.8E-06 0.20 1.8% ensg00000174074, sppl3
A1 is the associated (minor) allele. MAF, minor allele frequency. b, effect size expressed as the number of standard deviations change in phenotype for each copy of the
associated allele. ‘‘Var expl,’’ population phenotypic variance explained. Genes within 30 kb of the SNP are shown where applicable. For leptin and fasting plasma
glucose, there were no results with p#10
25; instead, the single best result is given.
doi:10.1371/journal.pgen.1000365.t003
Table 3. cont.
GWAS on the Island of Kosrae
PLoS Genetics | www.plosgenetics.org 10 February 2009 | Volume 5 | Issue 2 | e1000365Together, these data suggest that Kosraens segregate many of
the common variants that have been identified in Caucasian
populations, and that effect sizes for a majority of those variants on
Kosrae is not detectably different from that observed in
Caucasians despite a dramatically different population history
and environment. The empirical similarity of these genetic
architectures lends support to the concept of combining associa-
tion studies across populations to take advantage of neutrally
Figure 5. Quantile-quantile plots showing genome-wide association results for five selected quantitative traits. The extended Kosrae
pedigree was broken into sibships. Association for each quantitative trait was evaluated using PLINK/QFAM-Total. Scores were adjusted for inflation
due to excess relatedness using genomic control. Panel A highlights SNPs with known association to HDL-C, LDL-C and triglycerides. Panel B shows
an excess of association for thyroid stimulating hormone (TSH), while association scores for fasting plasma glucose (FPG) follow the null distribution.
doi:10.1371/journal.pgen.1000365.g005
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Caucasian Kosraen
SNP Study Nearest Gene(s) Allele Freq P-value b on 500 k Freq P-value b Phet b Phet Freq
BMI
rs9939609
1 FTO A 0.45 2.0E-20 0.10 same 0.12 0.10 0.14 0.65 0.16
rs17782313
2 MC4R C 0.28 2.8E-15 0.05 same 0.08 0.55 20.06 0.26 0.42
Height
rs6763931
3 ZBTB38 A 0.48 1.4E-27 0.07 rs6440003 0.25 0.16 0.08 0.88 2
rs724016
4 ZBTB38 G 0.48 8.3E-22 0.37 rs6440003 0.25 0.16 0.08 2.8E-06 2
rs1042725
4 HMGA2 T 0.49 2.7E-20 20.48 same 0.55 0.70 0.01 5.5E-42 0.84
rs6060369
4 GDF5-UQCC C 0.36 1.4E-16 0.44 same 0.31 0.51 0.05 5.2E-08 0.85
rs798544
3 GNA12 G 0.72 6.5E-15 0.06 same 0.47 0.18 0.08 0.68 0.18
rs3748069
3 GPR126 A 0.73 4.5E-14 0.07 rs7755109 0.25 0.36 0.07 0.92 2
rs1812175
3 HHIP C 0.81 9.7E-12 0.08 same 0.63 0.05 0.11 0.60 0.48
rs7153027
3 TRIP11, FBLN5, ATXN3,
CPSF2
A 0.61 1.1E-10 0.06 same 0.77 0.46 20.06 0.14 0.47
rs6830062
3 LCORL, NCAPG T 0.84 1.3E-10 0.06 same 0.94 0.86 0.03 0.80 0.60
rs3760318
3 CRLF3, ATAD5, CENTA2,
RNF135
C 0.64 1.8E-09 0.06 rs7225461 0.56 0.31 0.07 0.90 2
rs2282978
3 CDK6, PEX1, GATAD1,
ERVWE1
C 0.37 9.8E-09 0.06 same 0.06 0.61 20.07 0.33 0.10
rs967417
3 BMP2 C 0.57 1.5E-08 0.04 same 0.13 0.90 0.03 0.97 0.05
rs4743034
3 ZNF462 A 0.24 2.1E-08 0.05 same 0.14 0.41 20.10 0.21 0.71
rs678962
3 DNM3 G 0.16 3.2E-08 0.05 rs12411264 0.14 0.77 20.01 0.06 2
rs4533267
3 ADAMTS17 A 0.28 3.3E-08 0.06 same 0.40 0.19 0.07 0.76 0.51
rs7846385
3 PXMP3, ZFHX4 C 0.34 4.7E-08 0.05 same 0.16 1.00 20.01 1.00 0.26
rs2562784
4 SH3GL3-ADAMTSL3 G 0.17 6.4E-08 0.34 same 0.42 0.20 20.08 2.9E-11 0.15
rs4794665
3 NOG, DGKE, TRIM25, COIL,
RISK
A 0.53 9.9E-08 0.04 same 0.26 0.65 20.04 0.40 0.33
HDL-C
rs1800775
5 CETP C 0.43 1.0E-73 20.18 same 0.58 1.7E-04 20.19 0.86 0.55
rs4846914
5 GALNT2 G 0.42 2.0E-13 20.07 same 0.58 0.58 20.03 0.34 0.54
rs2156552
5 LIPG, ACAA2 A 0.20 2.0E-07 20.07 same 0.03 0.45 0.10 2 0.24
rs3890182
5 ABCA1 A 0.09 3.0E-10 20.10 same 0.37 0.18 0.07 6.8E-04 0.12
rs328
5 LPL G 0.13 9.0E-23 0.17 rs10503669 0.98 0.04 20.38 22
LDL-C
rs12654264
5 HMGCR T 0.42 1.0E-20 0.10 same 0.42 2.4E-05 0.18 0.07 1.00
rs693
5 APOB A 0.49 1.0E-21 0.12 same 0.09 0.15 0.11 0.88 0.05
rs4420638
5 APOE cluster G 0.18 1.0E-60 0.19 same 0.21 1.9E-07 0.30 0.05 0.92
rs16996148
5 CILP2,PBX4 T 0.06 3.0E-08 20.10 same 0.17 0.58 20.03 0.11 0.66
Triglycerides
rs328
5 LPL G 0.13 2.0E-28 20.19 rs10503669 0.98 0.53 0.10 22
rs693
5 APOB A 0.49 2.0E-07 0.08 same 0.09 0.17 0.10 0.81 0.05
rs12130333
5 ANGPTL3, DOCK7,ATG4C T 0.24 2.0E-08 20.11 same 0.04 0.87 0.02 2 0.44
rs780094
5 GCKR T 0.38 3.0E-14 0.13 same 0.27 1.5E-02 0.12 0.88 0.68
rs17321515
5 TRIB1 G 0.40 4.0E-17 20.08 same 0.70 1.3E-02 20.11 0.47 0.20
rs16996148
5 CILP2,PBX4 T 0.06 4.0E-09 20.10 same 0.17 1.6E-03 20.16 0.25 0.66
rs4846914
5 GALNT2 G 0.42 7.0E-15 0.08 same 0.58 1.6E-03 20.16 2.0E-06 0.54
rs17145738
5 BCL7B,TBL2,MLXIPL T 0.12 7.0E-22 20.14 same 0.03 0.79 20.02 2 0.73
Fasting plasma glucose
rs563694
6 G6PC2 A 0.65 6.4E-33 n/a same 0.95 0.28 0.21 2 0.13
rs1799884
7 GCK A 0.20 1.0E-09 0.06 same 0.14 0.06 0.15 0.26 0.82
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confirmation and fine mapping of common disease variants.
Discussion
We describe genome-wide association analyses in a population-
based cohort with extensive family structure, and explore the value
of genetic studies in a population isolate with high levels of linkage
disequilibrium and relative allelic homogeneity [4]. Our goal was
to take advantage of the population genetic features of this isolated
population while maximizing the power to detect associations. We
broke the extended Kosrae pedigree into sibships to create a
computationally tractable dataset that uses as many genotyped
individuals as possible. Empirical power calculations show that
testing for association both within and between sibships gives more
power than within-family tests alone. We used permutation testing
and genomic control to correct for score inflation. Association to
true biological variants was clearly observed for several known
lipid loci, including APOE, CETP, HMGCR and APOC3/A5. Our
ability to detect multiple loci with known association indicates that
our analytic strategy is adequate to identify true disease loci.
Suggestive evidence for association was observed for thyroid
stimulating factor (TSH) to SNPs in the gene encoding thyroid
transcription factor 2 (TTF-2), a strong biological candidate with
no previously known association. Associations near APOC3/A5 for
triglycerides and near TTF-2 for TSH also highlight the possibility
of island-specific variants or differences in LD between Kosraens
and Caucasians that may be useful in identifying causal variants
common to both populations.
Our study tests the hypothesis that reduced genetic diversity,
genetic drift and/or natural selection might have resulted in a class
of common alleles with large effects on metabolic phenotypes.
Reduced diversity is evident in our study and consistent with our
earlier observations [4], with 20% of the SNPs (n.109,000)
passing technical quality filters having minor allele frequencies
,0.01 in Kosraens. Empirical estimates of study power showed
that we have 95% power to observe effects explaining $5%
phenotypic variance at p,10
26. And yet, no large effects of this
sort were detected. This is similar to the pattern observed in other
populations, where the majority of common variants have
individually modest effects, typically explaining #2% of pheno-
typic variance [21,22,35–37]. Our genome-wide data expand on
and confirm previous work suggesting that many genes of small
effect influence trait variation in both outbred and founder
populations such as Kosrae [38].
While our cohort encompasses ,65% of the adult population
on Kosrae, limited sample size, coupled with substantial
relatedness between study participants, reduces the power of our
study in comparison to recently published genome-wide associa-
tion studies and meta-analyses for common diseases. It is
interesting, given the widespread and reasonable predictions that
gene-by-gene and gene-by-environment effects modulate marginal
associations, that a comparison of allele frequencies and the
direction/magnitude of effects for loci originally identified in
Caucasian cohorts shows that a majority with statistically
indistinguishable effects in Kosraens.
We also note that the set of biologically relevant variants
influencing metabolic traits is unlikely to be wholly identical
between Kosraens and Caucasians. For example, heritability of
total plasma cholesterol is similar in Kosraens and Caucasians, but
the population mean is approximately 20 mg/dL lower in
Kosraens. Variants specific to Kosraens may underlie the
phenotypic difference between populations; these variants may
lie in novel genes or genes previously implicated in disease or trait
variation. Identification of such variants in Kosraens and other
ethnic groups may shed light on biological pathways and aspects of
disease biology that might otherwise be overlooked in purely
Caucasian studies.
Caucasian Kosraen
SNP Study Nearest Gene(s) Allele Freq P-value b on 500 k Freq P-value b Phet b Phet Freq
Thyroid Stimulating Hormone
rs4704397
8 PDE8B A 0.48 1.3E-11 0.21 same 0.77 3.0E-04 0.25 0.60 0.28
C-Reactive Protein
rs7553007
9 CRP A 0.33 2.2E-26 20.20 same 0.38 0.03 20.11 0.06 0.86
rs1892534
9 LEPR A 0.38 6.5E-21 20.17 same 0.82 0.13 20.09 0.18 0.03
rs7310409
9 HNF1A A 0.39 6.8E-17 20.15 rs2393791 0.44 3E-04 20.16 0.82 2
rs780094
9 GCKR A 0.41 6.7E-15 0.14 same 0.73 0.99 7E-4 0.01 0.12
rs4129267
9 IL6R A 0.40 2.0E-8 20.10 rs4537545 0.36 0.02 20.10 1.00 2
1Frayling et al. (2007) Science 316:889.
2Loos et al. (2008) Nat Genet 40:768.
3Gudbjartsson et al. (2008) Nat Genet 40:609.
4Lettre et al. (2008) Nat Genet 40:584.
5Kathiresan et al. (2008) Nat Genet 40:189.
6Chen et al. (2008) J Clin Invest 118:2620.
7Weedon et al. (2005) Diabetes 54:576.
8Arnaud-Lopez et al. (2008) Am J Hum Genet 82:12.
9Ridker et al. (2008) Am J Hum Genet 82:1185.
For SNPs not directly genotyped on the Affymetrix array (n=9), association results are reported for a proxy on the Affymetrix chip with strong correlation (r
2$0.95) to
the original SNP in both HapMap Caucasian and Asian populations. The effect size (b) is expressed as the number of standard deviations change in phenotype for each
copy of the associated allele. ‘‘Phet b’’ denotes p-values for the test of heterogeneity between the Caucasian and Kosrae effect sizes. SNPs with low frequency in Kosraens
(MAF,0.05; n=6) were omitted from the test of heterogeneity for effect sizes. ‘‘Phet Freq’’denotes p-values for similarity between frequency of the risk allele in
Caucasians and Kosraens. SNPs not directly genotyped on the Affymetrix array were omitted from the comparison of allele frequencies. ‘‘2,’’ not analyzed.
doi:10.1371/journal.pgen.1000365.t004
Table 4. cont.
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hampered by the lack of genome-wide scans in cohorts with an
ethnicoriginandpopulation historysimilar toKosrae.Themajority
of studies to date have been performed in Caucasians. Further work
is required to assess in Kosraens the extent of genetic drift and
selection under strikingly different environmental pressures. Rep-
lication of true ‘‘island’’ variants would likely be difficult or
impossible in existing Caucasian cohorts and underscores the need
for the inclusion of diverse ethnic groups in genetic studies.
It is also worth noting that although extended LD on Kosrae
facilitates locus identification through greater genome coverage, it
hampers fine-mapping efforts. In the event that novel association
results can be validated or replicated in other populations, a
comparison of LD patterns between populations will likely be
important to identify the causal variant.
While future methods will no doubt improve on our analytical
approach, we describe approaches which may be useful to others
undertaking genetic studies in population isolates. Tools for
validating pedigrees with genetic data greatly facilitated the review
of millions of pairwise IBD estimates, highlighted inconsistencies in
the reported pedigree, and assisted in the identification of
previously unknown first-degree relationships. We show that
applying a combined within- and between-family test of
association to the subunits of a large extended pedigree increases
study power. In addition, the simulation framework we describe
for empirical power calculations will be useful for evaluating and
comparing the performance of other methods for association
analyses as they become available.
The current analysis assesses the role of common variants
influencing phenotype on the island of Kosrae, but does not
evaluate the role of rare variants. In fact, the analytic challenges
posed by extensive relatedness in this cohort and the previously
demonstrated extended LD in the population suggest that
Kosraens may be particularly informative for other analytic
methods such as homozygosity mapping. Recent, severe popula-
tion bottlenecks and subsequent rapid expansion have greatly
enriched Kosraens for long stretches of homozygosity. These
homozygous segments act as proxies for rare recessive variants
segregating in the population and are predicted to greatly increase
our power to detect such variants. We are currently developing
methods for homozygosity mapping in this unique population. We
anticipate that homozygosity approaches for the detection of rare,
recessive alleles, coupled with direct sequencing studies to
characterize variation on Kosrae not captured by existing
genotyping platforms, will complement the association studies for
common variants presented here. Together, these three approach-
es will provide a more complete picture of genetic variation in
population isolates, and the underlying role of drift and natural
selection on the architecture of metabolic traits on Kosrae.
Materials and Methods
Ethics Statement
The study was approved by the Institutional Review Boards at
all participating institutions, including Rockefeller University
(protocol #JFN-0282-0707), Massachusetts Institute of Technol-
ogy (COUHES protocol #0602110607) and Massachusetts
General Hospital (protocol #2006-P-000211/6; MGH). All
patients provided written informed consent (in English or Kosraen)
for the collection of samples and subsequent analysis.
Sample Collection
During screenings performed in 1994, 2001 and 2003, patients
were recruited by public announcements and came to the clinic
following an overnight fast. The 1994 screen was described
previously [7,12]. Briefly, informed consent was obtained from
each patient (forms available in Kosraen), along with self-reported
information on identity of family members, medical history,
current medications, lifestyle, diet, exercise, and ethnicity. Blood
was collected from Kosraens in the fasted state and centrifuged.
Plasma and buffy coats were frozen and shipped to Rockefeller
University for serological assays and DNA extraction, respectively.
IRB approval was obtained from all participating institutions.
Clinical Data
Quantitative trait measurements were log- or square root-
transformed to approach normality, adjusted for age and gender
where applicable, and converted to Z-scores. An average Z-score
was used for patients screened in multiple collection years or
monozygotic twins. Individual trait descriptions are available in
the Supplemental materials (Dataset S1).
Genotypes were analyzed for association with fifteen quantita-
tive traits: body mass index (BMI), height, weight, waist
circumference, plasma leptin, percent body fat, diastolic and
systolic blood pressure, fasting plasma glucose, thyroid stimulating
hormone, HDL-C, LDL-C, total plasma cholesterol, triglycerides
and high-sensitivity plasma C-reactive protein.
Genotyping
Data from the Affymetrix 500 k assay were generated at
Affymetrix, South San Francisco, CA. Genotypes were called with
the BRLMM algorithm. A minimum call rate of 95% was
required for each chip (Table S1). The two chips in the 500 k
assay (enzyme fractions Sty and Nsp) were matched by genotype
concordance and gender concordance between each chip and the
clinical data for that sample. Of the ,3,100 subjects ascertained,
2,906 individuals were successfully genotyped according to these
criteria. Per-SNP quality filters included: mapping to a unique
genomic location, minimum per-SNP call rate of 95%, fewer than
10 Mendelian errors, and minor allele frequency (MAF) .0.
408,775 SNPs met these criteria. For the purposes of SNP quality
control, allele frequencies were estimated assuming all 2,906
genotyped individuals were unrelated. Hardy-Weinberg equilibri-
um was not used as a quality filter, as it cannot be assessed by
standard formulae in our highly related cohort.
Autosomal SNPs with MAF$0.01 were analyzed for association
with each trait, where MAF was calculated using the individuals
phenotyped for that trait. Sibling relationships were accounted for
according to default procedures in PLINK. The number of SNPs
analyzed ranged from 332,890 (TSH) to 345,026 (Height).
Pedigree
Study participants provided names and birthdates of their
relatives during the patient interview. Information from multiple
patient records was cross-referenced and used to reconstruct
extended pedigrees. Relationships reported by subjects in the 1994
screen were validated genetically using Mendelian inheritance
checks and identity-by-state analyses with microsatellite markers
and the pedigree was modified to reflect the genetically accurate
relationships [12,39]. Subjects screened in 2001 and 2003 were
originally incorporated into the pedigree on the basis of
genealogical information.
SNP genotyping data were subjected to identity-by-descent
estimation using PLINK [13]. Thresholds of IBD sharing for
parent-child, full-sibling, and half-sibling relationships were
empirically determined from the distribution of genome-wide
IBD scores for known relationships. We used empirical ratios of
total sharing and the proportion of genome shared in 0, 1, or 2
GWAS on the Island of Kosrae
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evidence supported putative relationships reported in the Kosrae
pedigree. A complete list of putative first-degree relative pairs
(parent-child, sibling, half-sibling) was extracted from the pedigree.
For each putative first-degree relative pair, we examined genetic
evidence supporting or refuting that relationship and corrected
relationships in the Kosrae pedigree accordingly. For example, in
a set of individuals forming a putative nuclear family, we verified
that all combinations of parent-child relationships and sibling
relationships met our criteria for genetic relatedness. ‘‘Placehold-
er’’ individuals were added to the pedigree as necessary to reflect
genetic relationships, such as the addition of a ‘‘placeholder’’
father for a newly-discovered maternal half-sibling. The correction
of numerous relationship pairs and our ability to detect cryptic
relationships enabled consolidation or elimination of over 70 non-
genotyped ancestors, resulting in ‘‘tightening’’ of the Kosrae family
tree.
Thirteen pairs of monozygotic twins and thirty-five duplicate
sample pairs were identified by genotype similarity. Sample
identity was confirmed from patient records (name, birth date) and
one subject from each pair was included in the association
analyses.
We identified 58 offspring from consanguineous matings, where
a common ancestor could be identified in the extended Kosrae
pedigree; these consanguineous offspring were excluded from
association analyses. An additional nine individuals were excluded
from the dataset, as they self-reported non-Micronesian ethnicities
and could not be connected to the pedigree.
Breaking the Pedigree
Three approaches were considered to break the extended
pedigree into smaller units.
Founders consist of a filtered subset of sibships-without-parents,
such that any genotyped offspring of a founder sibship are
removed from the dataset. Founder sibships are drawn primarily
from the upper levels of the Kosrae family tree. For example, 582
‘‘founders’’ in 247 sibships were identified for the BMI phenotype.
Sibships without parents consist of two or more individuals known
to share both parents. Since the Kosrae cohort spans multiple
generations, members of one family group are frequently parents
or cousins of other family groups. Information about parents is
used to define a sibship; however, any genotyped parents are
considered only in the context of their own siblings. For BMI,
1,871 individuals were included in 467 sibships of size $2.
Nuclear families consist of two genotyped parents and one or more
offspring. Where one genotyped parent is available, offspring are
included as a sibship without parents and the genotyped parent is
included in the context of its own siblings. Where no genotyped
parents are available, individuals contribute as members of a
sibship without parents.
‘‘Sibships of size one’’ and ‘‘Unrelateds’’. Genome-wide
estimates of identity-by-descent (pihat) were used to select a subset
of distantly related individuals. Genotyped individuals were
randomly ordered, and individuals were selected if they were
related to every other member of the group below a set threshold.
A threshold of pihat #0.125 was used for individuals included in
the association analyses (‘‘sibships of size one’’), corresponding to a
relationship of first cousin or less. This selection process was
repeated for 1,000 iterations, after which the largest set of
individuals was identified for further use. These individuals
contribute in the Between-family association score. For example,
202 ‘‘sibships of size one’’ contribute to the analysis for BMI.
A more stringent threshold of pihat #0.08, applied to the entire
dataset of 2,906 study participants, resulted in n=133 individuals
related as less than first cousins. These individuals are treated as
independent observations (‘‘unrelateds’’), suitable for use in any
analysis requiring unrelated individuals (e.g., calculating allele
frequencies, LD).
Selection of a scheme to break the extended pedigree. In
selecting a method to break the extended Kosrae pedigree, we
considered three factors: maximum use of genotyped individuals (a
rough proxy for power); minimal inflation of the association test
statistic; and the practical consideration of retaining similar family
structures across multiple traits.
‘‘Founders’’ (n=582) have the fewest relationships with other
individuals in the complete pedigree and were expected to
minimize association score inflation due to excess relatedness
between families. However, the exclusion of over 2,300 genotyped
individuals from the analysis and concomitant loss of power
persuaded us against this family configuration.
Sibships-without-parents and nuclear families include similar
numbers of individuals for a given trait. We note that the optimal
configuration of nuclear families varies across phenotypes, whereas
sibships-without-parents minimize differences in family structure
across multiple traits. Individuals lacking a phenotype are simply
omitted from a sibship and do not radically change the number of
sibships available for analysis. The extended Kosrae pedigree was
broken into sibships-without-parents separately for each trait and
analyzed for association.
‘‘Spiked’’ Datasets for Data Simulations
We performed empirical evaluations of power for each
association method using simulated datasets. We ‘‘spiked’’ an
effect of known size (explaining an additional 0.5%, 1% or 2%
variance) into an existing Kosraen phenotype (BMI) and analyzed
this modified phenotype with observed Kosraen genotypes,
thereby retaining the true genotype-phenotype correlation be-
tween related study subjects. A subset of 1,000 SNPs across the
genome were randomly selected and filtered to retain SNPs with
MAF.0.01. The remaining 770 SNPs were analyzed for
association with the spiked phenotype. A total of 770 spiked
phenotypes were generated, in which each phenotype was altered
to reflect association to a different SNP of the random subset.
These 770 phenotypic datasets were analyzed for association to the
spiked SNP using FBAT and PLINK/QFAM under an additive
model [13,40].
Calculating Effective Sample Size
We used empirical power estimates from the BMI ‘‘spiking’’
experiment and the module for variance components QTL
association for sibships in the Genetic Power Calculator [20] to
estimate the effective sample size of our cohort, or the number of
unrelated individuals required to obtain power equivalent to that
provided by the Kosraen sibships. Power calculations were
performed assuming no dominance, minor allele frequency of
0.2, and direct genotyping of the causal variant. For BMI, the
2,073 individuals included in the association analysis have power
equivalent to ,840 unrelated individuals.
Association Analyses
Quantitative trait data were analyzed under an additive model
using the QFAM module of PLINK [13]. Nominal scores were
permuted to obtain an empirical p-value while maintaining
familial correlation between genotype and phenotype. The
permutation procedure employed by QFAM corrects for related-
ness within families. Between-family relatedness is not addressed in
QFAM and is the major source of score inflation (see Dataset S1,
GWAS on the Island of Kosrae
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introduced by relatedness between family units (sibships) [19].
We account for multiple testing by assuming a threshold of
p#5610
28 for genome-wide significance, following the work of
Pe’er et al (2008) and Dudbridge and Gusnanto (2008) [41,42].
This approach assumes approximately 10
6 independent tests
across the genome and requires an additional p#0.05. This
significance threshold is likely conservative on Kosrae, where the
true number of independent tests is likely to be smaller because of
the extended LD, and so alleviates the multiple testing burden.
Comparison of Allele Frequencies for Known Associated
Loci
Association results for known, associated loci were drawn from
studies in large Caucasian cohorts for multiple traits. For each
Caucasian risk allele where the SNP was directly genotyped in
Kosraens, we determined its frequency in HapMap CEU. We
identified SNPs on the Affymetrix array that have frequencies in
HapMap CEU within 2% of the frequency of the risk allele in
HapMapCEU.ForeachSNPinthatset,wecalculatedthedifference
in allele frequency between HapMap CEU and Kosrae. These values
were used to generate an empirical distribution of allele frequency
differences. For the risk allele, we calculate the difference in allele
frequency between HapMap CEU and Kosrae, and place this
difference on the empirical distribution to determine significance.
Comparison of Effect Sizes for Known Associated Loci
Association results for known, associated loci were drawn from
studies in large Caucasian cohorts for multiple traits. Caucasian
loci were limited to SNPs directly genotyped in Kosraens, or
where a strong proxy was genotyped in Kosraens (r2$0.95 in
HapMap CEU and ASN). SNPs with MAF,0.05 on Kosrae were
omitted from comparison, as power is low to estimate effect sizes
accurately for rare SNPs. We assumed the Caucasian b estimates
for each of the traits to be a fixed value. A test of heterogeneity for
the magnitude and direction of the effect in Caucasians and
Kosraens was performed as follows [43]:
bk{bc
sbk
  
  *T: Where bk
and bc are the effect sizes for Kosrae and Caucasian populations,
sbkis the standard deviation on the bk, and is distributed like a T.
Supporting Information
Figure S1 Marker quality control for SNPs in the Affymetrix
500 k assay.
Found at: doi:10.1371/journal.pgen.1000365.s001 (0.01 MB PDF)
Figure S2 Excess relatedness is the major source of association
score inflation. Association score inflation was evaluated in three
subsets of the Kosrae cohort using the BMI phenotype. Score
inflation is greatly reduced in ‘‘unrelated’’ (less than first cousins)
individuals and in a set of sibships filtered to remove all parent-
child relationships between sibships, as compared to all available
sibships in the cohort.
Found at: doi:10.1371/journal.pgen.1000365.s002 (0.06 MB PDF)
Figure S3 Quantile-quantile plots showing genome-wide asso-
ciation results for 15 quantitative traits. For each trait, the number
of individuals used in the analysis, heritability, and genomic
control correction factor (lambda) are given.
Found at: doi:10.1371/journal.pgen.1000365.s003 (0.17 MB PDF)
Table S1 Genotyping statistics for the Affymetrix 500 k assay.
Found at: doi:10.1371/journal.pgen.1000365.s004 (0.04 MB
DOC)
Dataset S1 Supplemental Trait Descriptions.
Found at: doi:10.1371/journal.pgen.1000365.s005 (0.81 MB
DOC)
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